![](https://healthpulse.news/wp-content/uploads/2023/08/Quviviq-300x150.webp)
Quviviq (Daridorexant): FDA-Approved Drug for Insomnia
Amongst sleep disorders, insomnia stands as one of the most common and debilitating conditions affecting individuals worldwide. With the FDA approval of Quviviq (daridorexant) in January 2022, there is renewed hope for people with insomnia. This article will review how Quviviq works, its dosage, available strengths, benefits, side effects, essential precautions, and warnings.